David Shaw’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-2,000
Closed -$402K – 4462
2023
Q3
$402K Sell
2,000
-14,878
-88% -$3.14M ﹤0.01% 3508
2023
Q2
$3.5M Buy
16,878
+2,794
+20% +$542K ﹤0.01% 2154
2023
Q1
$2.78M Sell
14,084
-3,958
-22% -$814K ﹤0.01% 2443
2022
Q4
$3.65M Buy
+18,042
New +$3.53M ﹤0.01% 2380
2022
Q2
– Sell
-11,640
Closed -$2.64M – 5568
2022
Q1
$2.64M Buy
+11,640
New +$2.74M ﹤0.01% 3027
2020
Q3
– Sell
-23,280
Closed -$3.32M – 4003
2020
Q2
$3.32M Buy
+23,280
New +$3.22M ﹤0.01% 1996
2018
Q2
– Sell
-30,497
Closed -$4.24M – 3798
2018
Q1
$4.24M Buy
+30,497
New +$4.48M 0.01% 1516

Other funds holding LH

David Shaw's LH Position: Q3 2026 in Review

David Shaw increased its Labcorp (LH) stake by 505% in Q3 2026, buying an estimated $62.7M and bringing the position to 242,093 shares worth $74.6M. The position accounts for 0.04% of the portfolio, ranked #571.

David Shaw first reported a position in LH in Q4 2013 and has held it in 46 quarters since. The position peaked at $199M in Q1 2022. 1,089 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • David Shaw held 242,093 shares of Labcorp worth $74.6M as of Q3 2026.
  • David Shaw bought 202,062 Labcorp shares in Q3 2026, an estimated $62.7M.
  • Labcorp made up 0.04% of David Shaw's portfolio in Q3 2026, its #571 holding.
  • David Shaw first reported a position in Labcorp in Q4 2013 and has held it in 46 quarters since.
  • David Shaw's Labcorp position peaked at $199M in Q1 2022.
  • 1,089 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.